Contracts › 75A50122C00080
75A50122C00080: Venatorx Pharmaceuticals: Antibiotic for Amr and Biothreat Pathogens
Awarded to Venatorx Pharmaceuticals Inc by Office of Assistant Secretary for Preparedness and Response.
$72.1Mobligated
$318.6Mpotential value
31 December 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122C00080 |
|---|---|
| Awardee | Venatorx Pharmaceuticals Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | PA |
| Offers received | 3 |
| Period of performance | 27 September 2022 to 31 December 2028 |
| Potential end | 22 September 2032 |
| Estimated recompete solicitation | ~Q3 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record